Skip to content

Orange Juice Consumption and Cognitive Function

Effect of Chronic Orange Juice Consumption on Cognitive Function in Healthy Older Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01312610
Acronym
OJOC
Enrollment
40
Registered
2011-03-10
Start date
2010-09-30
Completion date
2011-09-30
Last updated
2011-11-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nerve Degeneration

Keywords

orange juice, cognitive function, flavonoids, flavanones

Brief summary

This study is investigating the effect of 8 weeks of orange juice supplementation on executive function in healthy older adults. The study is a controled, double-blind, crossover trial and involves a 8 week supplementation with a high flavonone orange juice and a carbohydrate-matched control. Volunteers consume 500ml of either the test juice or the control juice per day for an 8 week period. There is then an 8 week washout period before subjects proceed to the other arm of the study. Subjects are randomly assigned to either arm at the beginning of the study. Measures of cognitive function will be administered pre and post both test and control interventions. Blood pressure will also be measured and blood and urine samples will be collected to assess absorption of from the juice. A sub-sample of volunteers will undergo MRI imaging pre- and post intervention to acquire cerebral blow flow information.

Interventions

DIETARY_SUPPLEMENTHigh flavanone orange juice

High flavonone orange juice drink.

DIETARY_SUPPLEMENTControl orange juice

Orange beverage, low flavanone content, matched for total carbohydrate content, individual sugar profile, vitamin C

Sponsors

University of Reading
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
60 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* In good general health i.e. no major health condition such as diabetes * BMI \< 30 * Cholesterol \< 6 and BP \< 150/90 * Not on blood pressure medication or blood thinning medication such as aspirin - No learning difficulty such as dyslexia

Exclusion criteria

* Diabetes * Gastro-intestinal disease * High BMI * Cholesterol and BP * Smoker * On blood pressure medication or blood thinning medication such as aspirin * Dyslexic/dyspraxic * Depression or history of depression

Design outcomes

Primary

MeasureTime frameDescription
Executive function - Attentionchange in attention from baseline and 8 weeksAssessment by human cognitive test battery delivered by computer and human operator. Assessments will be carried out at baseline and at the end of each intervention arm.

Secondary

MeasureTime frameDescription
Plasma flavanoneschange from baseline to 8 weeksBy High performance liquid chromatography
Blood pressurechange from baseline to 8 weeksBlood pressure measurement

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026